A 16-µg dose of lubiprostone, a medication used in the management of constipation, improved or preserved estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD), ...

Chronic Kidney Disease (CKD) signifies persistent kidney damage lasting over three months. The best indicator of kidney function is the Glomerular Filtration Rate (GFR), which measures how effectively ...

Chronic kidney disease (CKD) is a major health issue worldwide. Many patients end up requiring regular dialysis to avoid kidney failure and stay alive. Despite the severity of the condition, there are ...

Chronic kidney disease (CKD) is a progressive condition in which the kidneys are damaged and can’t filter blood effectively. This can eventually lead to a buildup of waste and fluid in the body. In ...

Chronic Kidney Disease (CKD) indicates prolonged kidney damage over three months, often undetectable until significant harm occurs. Key risk factors include diabetes, high blood pressure, and obesity.

Credit: Getty Images In a 3-part series, authors discussed the neurocognitive impact of long-term medications in patients with CKD. Patients with CKD may be more susceptible to cognitive adverse drug ...

Compared with using stool softeners, taking lubiprostone was significantly associated with lower risks of a composite adverse kidney outcome and steeper eGFR decline. The risk for kidney function ...

STOCKHOLM — Improvements in kidney function outcomes observed with glucagon-like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes extend to patients who are overweight or obese but ...

Diagnosed prevalent cases of chronic kidney disease are projected to reach 22.97 million across the 7MM by 2033. This increase highlights the impact of CKD on global health. Diagnosed prevalent cases ...